Medical System Network Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	132,186	122,387	115,361	109,551	106,685
Revenue Growth (YoY)	8.01%	6.09%	5.30%	2.69%	2.33%
Cost of Revenue	78,440	71,651	67,435	63,629	62,256
Gross Profit	53,746	50,736	47,926	45,922	44,429
Selling, General & Admin	50,432	40,555	37,448	36,511	34,508
Other Operating Expenses	-	7,027	6,645	6,247	6,068
Operating Expenses	50,432	47,582	44,093	42,758	40,576
Operating Income	3,314	3,154	3,833	3,164	3,853
Interest Expense	-343	-278	-288	-277	-183
Interest & Investment Income	14	7	4	5	6
Earnings From Equity Investments	-84	-	-	-	-
Other Non Operating Income (Expenses)	289	277	274	462	638
EBT Excluding Unusual Items	3,190	3,160	3,823	3,354	4,314
Gain (Loss) on Sale of Investments	-	-	78	-	112
Gain (Loss) on Sale of Assets	-518	332	13	7	-9
Asset Writedown	-35	-767	-445	-304	-411
Other Unusual Items	-88	-2	-20	-39	7
Pretax Income	2,549	2,723	3,449	3,018	4,013
Income Tax Expense	1,436	1,424	1,579	1,389	1,624
Earnings From Continuing Operations	1,113	1,299	1,870	1,629	2,389
Minority Interest in Earnings	-43	-37	-10	-19	5
Net Income	1,070	1,262	1,860	1,610	2,394
Net Income to Common	1,070	1,262	1,860	1,610	2,394
Net Income Growth	-15.21%	-32.15%	15.53%	-32.75%	8.92%
Shares Outstanding (Basic)	29	29	30	30	30
Shares Outstanding (Diluted)	29	29	30	30	30
Shares Change (YoY)	-	-2.80%	-0.36%	0.03%	-0.47%
EPS (Basic)	36.61	43.18	61.86	53.35	79.35
EPS (Diluted)	36.61	43.18	61.86	53.35	79.35
EPS Growth	-15.21%	-30.20%	15.95%	-32.77%	9.44%
Free Cash Flow	-	1,751	5,863	3,600	2,076
Free Cash Flow Per Share	-	59.91	194.98	119.29	68.81
Dividend Per Share	-	12.000	12.000	12.000	11.000
Dividend Growth	-	-	-	9.09%	10.00%
Gross Margin	40.66%	41.45%	41.54%	41.92%	41.64%
Operating Margin	2.51%	2.58%	3.32%	2.89%	3.61%
Profit Margin	0.81%	1.03%	1.61%	1.47%	2.24%
Free Cash Flow Margin	-	1.43%	5.08%	3.29%	1.95%
EBITDA	6,728	6,568	6,996	6,121	6,708
EBITDA Margin	5.09%	5.37%	6.06%	5.59%	6.29%
D&A For EBITDA	3,414	3,414	3,163	2,957	2,855
EBIT	3,314	3,154	3,833	3,164	3,853
EBIT Margin	2.51%	2.58%	3.32%	2.89%	3.61%
Effective Tax Rate	56.34%	52.30%	45.78%	46.02%	40.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.